Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: david who wrote (6742)	4/9/1998 5:44:00 PM
From: Colby	Read Replies (2) \| Respond to of 23519

This company @ 5 would be a joke. I agree the management has to prove themselves, although, I think they have done a reasonable job. It was the production thing that has really hurt the mngmt. team. But if they continue to penetrate foreign markets and get the FDA approval we are all looking for, I think that will add some credibility to them. We are not talking about a simple company or a simple product. There are a lot of hurdles to be jumped and the company for the most part has done a decent job. MUSE has been approved in 4 continents. The drug is for real; we are not talking about another Bre-X. The next quarter will be the telling quarter. This is when they get the salesforce ramped up, their advertising kicks in, and hopefully the FDA will give them approval. If, and it is if, VVUS can do these things, most of the variables will be eliminated. OH, yeah, we'll get a better idea of how PFE will affect the company this quarter as well. If they can successfully eliminate those variables (minus the pfe thing), I expect to see a sizeable runup in the later half of the year. Of course, that is just my opinion. Also, David, I hope that comment on insider selling @ 15 was complete and utter speculation and nothing more. Holding on, Colby 0